Lin Tao

Lin Tao


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2019 in Briefings in Bioinformatics
Verified
Journal Article
Open access
JHJiajun Hong
Jiajun Hong
YLYongchao Luo
Yongchao Luo
YZYang Zhang
Yang Zhang
JYJunbiao Ying
Junbiao Ying
WXWeiwei Xue
Weiwei Xue
FZFeng Zhu
Feng Zhu
Functional annotation of protein sequence with high accuracy has become one of the most important issues in modern biomedical studies, and computational approaches of significantly accelerated analysis process and enhanced accuracy are greatly desired. Although a variety of methods have been developed to elevate protein annotation accuracy, their ability in controlling false annotation rates remains either limited or not systematically evaluated. In this study, a protein encoding strategy, together with a deep learning algorithm, was proposed to control the false discovery rate in protein function annotation, and its performances were systematically compared with that of the traditional similarity-based and de novo approaches. Based on a comprehensive assessment from multiple perspectives, the proposed strategy and algorithm were found to perform better in both prediction stability and annotation accuracy compared with other de novo methods. Moreover, an in-depth assessment revealed that it possessed an improved capacity of controlling the false discovery rate compared with traditional methods. All in all, this study not only provided a comprehensive analysis on the performances of the newly proposed strategy but also provided a tool for the researcher in the fields of protein function annotation.

7 February 2025 in Biotechnology Advances
Verified
Journal Article
Closed access
SZSisi Zhu
Sisi Zhu
HXHongquan Xu
Hongquan Xu
YLYuhong Liu
Yuhong Liu
YHYanfeng Hong
Yanfeng Hong
HYHaowen Yang
Haowen Yang
LTLin Tao
Lin Tao

4 December 2024 in Journal of Pharmaceutical Analysis
Verified
Journal Article
Open access
YHYanfeng Hong
Yanfeng Hong
SZSisi Zhu
Sisi Zhu
YLYuhong Liu
Yuhong Liu
CTChao Tian
Chao Tian
HXHongquan Xu
Hongquan Xu
TXTian Xie
Tian Xie
Traditional Chinese medicine (TCM) is an ancient medical system distinctive and effective in treating cancer, depression, coronavirus disease 2019 (COVID-19), and other diseases. However, the relatively abstract diagnostic methods of TCM lack objective measurement, and the complex mechanisms of action are difficult to comprehend, which hinders the application and internationalization of TCM. Recently, while breakthroughs have been made in utilizing methods such as network pharmacology and virtual screening for TCM research, the rise of machine learning (ML) has significantly enhanced their integration with TCM. This article introduces representative methodological cases in quality control, mechanism research, diagnosis, and treatment processes of TCM, revealing the potential applications of ML technology in TCM. Furthermore, the challenges faced by ML in TCM applications are summarized, and future directions are discussed.

22 September 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
SLShuiping Liu
Shuiping Liu
LCLu Chen
Lu Chen
YZYintao Zhang
Yintao Zhang
YZYing Zhou
Ying Zhou
YHYing He
Ying He
FZFeng Zhu
Feng Zhu
As the most prevalent internal modification in eukaryotic RNAs, N6-methyladenosine (m6A) has been discovered to play an essential role in cellular proliferation, metabolic homeostasis, embryonic development, etc. With the rapid accumulation of research interest in m6A, its crucial roles in the regulations of disease development and drug response are gaining more and more attention. Thus, a database offering such valuable data on m6A-centered regulation is greatly needed; however, no such database is as yet available. Herein, a new database named ‘M6AREG’ is developed to (i) systematically cover, for the first time, data on the effects of m6A-centered regulation on both disease development and drug response, (ii) explicitly describe the molecular mechanism underlying each type of regulation and (iii) fully reference the collected data by cross-linking to existing databases. Since the accumulated data are valuable for researchers in diverse disciplines (such as pathology and pathophysiology, clinical laboratory diagnostics, medicinal biochemistry and drug design), M6AREG is expected to have many implications for the future conduct of m6A-based regulation studies. It is currently accessible by all users at: https://idrblab.org/m6areg/

21 December 2022 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
TYTian-Ci Yan
Tian-Ci Yan
ZYZi-Xuan Yue
Zi-Xuan Yue
HXHong-Quan Xu
Hong-Quan Xu
YLYu-Hong Liu
Yu-Hong Liu
YHYan-Feng Hong
Yan-Feng Hong
TXTian Xie
Tian Xie

6 October 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
KAKuerbannisha Amahong
Kuerbannisha Amahong
WZWei Zhang
Wei Zhang
YZYing Zhou
Ying Zhou
SZSong Zhang
Song Zhang
JYJiayi Yin
Jiayi Yin
FZFeng Zhu
Feng Zhu
Coronavirus has brought about three massive outbreaks in the past two decades. Each step of its life cycle invariably depends on the interactions among virus and host molecules. The interaction between virus RNA and host protein (IVRHP) is unique compared to other virus–host molecular interactions and represents not only an attempt by viruses to promote their translation/replication, but also the host's endeavor to combat viral pathogenicity. In other words, there is an urgent need to develop a database for providing such IVRHP data. In this study, a new database was therefore constructed to describe the interactions between coronavirus RNAs and host proteins (CovInter). This database is unique in (a) unambiguously characterizing the interactions between virus RNA and host protein, (b) comprehensively providing experimentally validated biological function for hundreds of host proteins key in viral infection and (c) systematically quantifying the differential expression patterns (before and after infection) of these key proteins. Given the devastating and persistent threat of coronaviruses, CovInter is highly expected to fill the gap in the whole process of the ‘molecular arms race’ between viruses and their hosts, which will then aid in the discovery of new antiviral therapies. It's now free and publicly accessible at: https://idrblab.org/covinter/